UNSPSC 51181619: Thiouracil

This classification denotes a nitric oxide synthetase inhibitor with the molecular formula C4H4N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 59X161SCYL, chemically known as 2,3-dihydro-2-thioxo-4(1h)-pyrimidinone but generally known as 2-thiouracil, which bears US NIH Compound Identifier 1269845. European Medicines Agency schedules Thiouracil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15541MIG. Most nations schedule thiouracil under HS 29335990 and SITC 51576.

As of Q4 2014, THIOURACIL remains the US FDA Preferred Term for this commodity. Thiouracil bears US NLM identifiers UMLS ID C0039957 and NCI Concept Code C29856. SMILES: S=C1[NH]C(=O)CC[NH]1.

UNSPSC 51181619 Thiouracil is a Commodity code for the procurement of thiouracil, a pharmaceutical chemical compound used primarily in veterinary and human medical applications. State and local governments procure thiouracil under this code for use in animal health programs, medical research facilities, university laboratories, and public health departments requiring this antithyroid agent. The issuing bodies sourcing this compound span state veterinary boards, county animal control and public health offices, university research facilities, and state departments of agriculture.

The source provides no recent state and local contract opportunities under this code. Without posted solicitations or awarded contracts, geographic spread and current procurement patterns cannot be characterized from available data.